AMC Alex Kerr Presentation %5bAutosaved%5d · ] } u ] o Z Z v ' µ Ç [ v ^ d Z } u [ E,^ & } µ v...
Transcript of AMC Alex Kerr Presentation %5bAutosaved%5d · ] } u ] o Z Z v ' µ Ç [ v ^ d Z } u [ E,^ & } µ v...
Biomedical Research Centre at Guy’s and St Thomas’ NHS Foundation Trust and King’s College London
CD16+ Monocyte Cell Therapy to Prevent Amputation in Critical Limb IschaemiaAlex KerrSenior Advanced Therapy Production ScientistNIHR Clinical Research FacilityGuy’s and St Thomas’ NHS Foundation Trust and King’s College London
PIs: Mr Ashish Patel PhD FRCSMr Bijan Modarai PhD FRCS
Biomedical Research Centre At Guy’s and St Thomas’ NHS Foundation Trust and King’s College London
BD Miltenyi BiotecCritical Limb Ischaemia• 20% of patients > 70yrs have peripheral vascular disease• Conventional treatments only benficial in ~50%• 5-10% progress to critical limb ischaemia (CLI)
Major vessels occluded Ischaemic tissue Gangrene
Biomedical Research Centre At Guy’s and St Thomas’ NHS Foundation Trust and King’s College London
Conventional Treatment
Biomedical Research Centre At Guy’s and St Thomas’ NHS Foundation Trust and King’s College London
Collateralisation
Biomedical Research Centre At Guy’s and St Thomas’ NHS Foundation Trust and King’s College LondonFurmston & Patel AS et al., J Cardiovasc Surg, 2014
Therapeutic Neovascularisation
Biomedical Research Centre At Guy’s and St Thomas’ NHS Foundation Trust and King’s College London
BD Miltenyi BiotecMonocytes“Non-Classical”
“Intermediate”
“Classical”
Biomedical Research Centre At Guy’s and St Thomas’ NHS Foundation Trust and King’s College London
BD Miltenyi BiotecCD16+ Monocytes are Angiogenicin vitro and in vivo
Control CD16+CD16-
* *ns
Control CD16+ CD16- Control CD16+ CD16-
* *ns
HUVEC Matrigel Assay CD16- CD16+
CD16+ monocytes
CD16- monocytes
Biomedical Research Centre At Guy’s and St Thomas’ NHS Foundation Trust and King’s College London
BD Miltenyi BiotecPre-Clinical Isolation
CD14
CD16
2. Negative depletionof CD56+ cells
4. Positive selection(CD14 Microbeads)
1. Ficoll preparation to isolate PBMCs
PBMCs
CD14
CD16
CD14
CD16
Biomedical Research Centre At Guy’s and St Thomas’ NHS Foundation Trust and King’s College London
BD Miltenyi BiotecGMP Isolation
Biomedical Research Centre At Guy’s and St Thomas’ NHS Foundation Trust and King’s College London
BD vs. Miltenyi BiotecRetention of Angiogenic Monocytes in CLI (ROAM-CLI) Physiological StudyLeukaphaeresis at King’s College Hospital
Overnight Cell Isolation
Day 1, Monday
Day 2, Tuesday
Day 4, Wednesday
Day 5, Friday 30 minute scan at Nuclear Medicine, Guy’s Hospital
Home
30 minute scan at Nuclear Medicine, Guy’s Hospital
Home
Injection of cells and 30 minute scan atNuclear Medicine, Guy’s Hospital
Home
Biomedical Research Centre At Guy’s and St Thomas’ NHS Foundation Trust and King’s College London
BD vs. Miltenyi BiotecPatient 186yrs oldRutherford Scale 5- rest pain- heel ulcer- dusky toes“No option”Planned for AKA
30 mins Post- Cell Delivery
24 hours 3 days
Injection site: 66% of whole-bodyUpper body: 22% of whole-body Injection site: 52% of whole-bodyUpper body: 31% of whole-bodyBiomedical Research Centre At Guy’s and St Thomas’ NHS Foundation Trust and King’s College London
Cell Distribution
Patient No.Startingproduct total cells(x108)
Lymphocytes (%) Monocytes (%)Totals cells final product(x106)
Viability (%) CD16+ cells (%) Sterility
1 8164 N/A N/A 340 88 69 No Growth after 5 days2 13600 80 20 233 92 65 No Growth after 5 days3 12292 49 41 217 97 80 No Growth after 5 days
4 24360 56 42 177 97 63 No Growth after 5 days
5 34816 60 40 170 96 73 No Growth after 5 days
Average 18646 61 36 227 94 70
Biomedical Research Centre At Guy’s and St Thomas’ NHS Foundation Trust and King’s College London
Study Summary
Biomedical Research Centre At Guy’s and St Thomas’ NHS Foundation Trust and King’s College London
BD vs. Miltenyi Biotec
• Prodigy scale-up• FACS• Multiple injections• Isolate heterogeneous monocytes (CD14+), then
skew towards pro-angiogenic phenotype in culture
Future Work
Biomedical Research Centre At Guy’s and St Thomas’ NHS Foundation Trust and King’s College London
AcknowledgementsAshish Patel Clinical Lecturer in Vascular SurgeryBijan Modarai Reader/BHF Senior Fellow in Vascular SurgeryAcademic Department of Vascular Surgery, King’s College London
Drew HopeChris FisherLaura FryJulie HewardAlex Beese-HernandezNIHR Clinical Research Facility, Guy’s and St Thomas’ NHS Foundation Trust and King’s College London